sb 203580 has been researched along with etoposide in 6 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 18,306 | 3,693 | 4,900 |
| Protein | Taxonomy | sb 203580 (IC50) | etoposide (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
| Caspase-3 | Homo sapiens (human) | 1 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biemann, HP; Blenis, J; Davis, RJ; Juo, P; Konz, RF; Kuo, CJ; Raingeaud, J; Reynolds, SE | 1 |
| Bushell, M; McKendrick, L; Morley, SJ | 1 |
| Chang, JH; Eberhardt, W; Frank, S; Mühl, H; Nold, M; Pfeilschifter, J | 1 |
| Boldt, S; Kolch, W; Weidle, UH | 1 |
| Baik, JH; Chaqour, B; Chung, KC; Kim, KH; Lau, LF; Min, YK | 1 |
| Canepa, E; Colla, R; De Ciucis, CG; Domenicotti, C; Furfaro, AL; Marengo, B; Marinari, UM; Pronzato, MA; Ricciarelli, R; Traverso, N | 1 |
6 other study(ies) available for sb 203580 and etoposide
| Article | Year |
|---|---|
Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caenorhabditis elegans Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Caspase 1; Caspases; Cysteine Endopeptidases; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Etoposide; fas Receptor; Helminth Proteins; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MAP Kinase Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Pyridines; Serpins; Signal Transduction; Sorbitol; Transcription, Genetic; Viral Proteins | 1997 |
Cleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogen-activated protein (MAP) kinase.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Arsenites; Calcium-Calmodulin-Dependent Protein Kinases; Caspase Inhibitors; Cell Survival; Etoposide; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; fas Receptor; Humans; Imidazoles; Immunoglobulin M; Jurkat Cells; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Peptide Initiation Factors; Phosphorylation; Poly(A)-Binding Proteins; Protein Biosynthesis; Pyridines; RNA-Binding Proteins; Signal Transduction; Sirolimus | 1998 |
Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells.
Topics: Apoptosis; Chemokines; Cladribine; Enzyme Inhibitors; Etoposide; Humans; Imidazoles; Interleukin-8; Leukocytes, Mononuclear; Pyridines; Serine Proteinase Inhibitors; Tosylphenylalanyl Chloromethyl Ketone; Triazenes; Tumor Necrosis Factor-alpha; U937 Cells | 1999 |
The role of MAPK pathways in the action of chemotherapeutic drugs.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Ceramides; Enzyme Activation; Enzyme Inhibitors; Etoposide; Female; Flavonoids; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Microtubules; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Paclitaxel; Pyridines; Skin Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2002 |
Expression of angiogenic factor Cyr61 during neuronal cell death via the activation of c-Jun N-terminal kinase and serum response factor.
Topics: Animals; Apoptosis; Blotting, Northern; Blotting, Western; Cell Death; Cysteine-Rich Protein 61; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Etoposide; Glutathione Transferase; Hippocampus; Imidazoles; Immediate-Early Proteins; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Neurons; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Pyridines; Rats; RNA; RNA, Messenger; Serum Response Factor; Signal Transduction; Stem Cells; Time Factors; Transfection | 2003 |
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Neoplasm Proteins; Neoplasm Staging; Nervous System Neoplasms; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction | 2013 |